SCHEMBL1534045

SCHEMBL1534045

CC(=CCC1CO1)C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5057657 1.00 ALDH1A1 (0.35) ALDH1A1
SCHEMBL1082659 0.86 ALDH1A1 (0.33) ALDH1A1
SCHEMBL1082658 0.86 ALDH1A1 (0.33) ALDH1A1
SCHEMBL28257048 0.83 ALDH1A1 (0.44) ALDH1A1
SCHEMBL5179069 0.82 ALDH1A1 (0.40) ALDH1A1
SCHEMBL29640472 0.82 ALDH1A1 (0.40) ALDH1A1
SCHEMBL20082 0.82 ALDH1A1 (0.40) ALDH1A1
SCHEMBL28302 0.82 ALDH1A1 (0.40) ALDH1A1
SCHEMBL30609972 0.82 ALDH1A1 (0.40) ALDH1A1
SCHEMBL20379990 0.81 ALDH1A1 (0.33) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3119829-B1 CONTROLLED CROSSLINKING OF LATEX POLYMERS WITH POLYFUNCTIONAL AMINES ENNIS PAINT INC (US) 2020-08-19 EP claimed
US-10717800-B2 Controlled crosslinking of latex polymers with polyfunctional amines ENNIS PAINT, INC. (US) 2020-07-21 US claimed
CN-106536590-B Controlled crosslinking of latex polymers with polyfunctional amines 恩尼斯涂料有限公司 2020-06-09 CN claimed
US-10081757-B2 Shale swelling inhibitors ISP INVESTMENTS LLC (US) 2018-09-25 US claimed
US-20170088694-A1 Controlled Crosslinking of Latex Polymers With Polyfunctional Amines ENNIS PAINT, INC. (US) 2017-03-30 US claimed
WO-2017049025-A1 CONTROLLED CROSSLINKING OF LATEX POLYMERS WITH POLYFUNCTIONAL AMINES ENNIS PAINT, INC. (US) 2017-03-23 WO claimed
US-20170081451-A1 Controlled Crosslinking of Latex Polymers With Polyfunctional Amines FLINT TRADING INC. 2017-03-23 US claimed
EP-3119829-A1 CONTROLLED CROSSLINKING OF LATEX POLYMERS WITH POLYFUNCTIONAL AMINES Ennis Paint Inc. (US) 2017-01-25 EP claimed
US-9499714-B2 Controlled crosslinking of latex polymers with polyfunctional amines ENNIS PAINT, INC. (US) 2016-11-22 US claimed
US-20150344767-A1 SHALE SWELLING INHIBITORS ISP INVESTMENTS INC. (US) 2015-12-03 US claimed
WO-2015142416-A1 CONTROLLED CROSSLINKING OF LATEX POLYMERS WITH POLYFUNCTIONAL AMINES ENNIS PAINT, INC. (US) 2015-09-24 WO claimed
US-20150259562-A1 Controlled Crosslinking of Latex Polymers With Polyfunctional Amines FLINT TRADING INC. 2015-09-17 US claimed
WO-2014088850-A2 SHALE SWELLING INHIBITORS ISP INVESTMENTS INC. (US) 2014-06-12 WO claimed
US-20080234433-A1 CATALYZED MULTIPLE GRAFTING POLYMERIZATIONS THE UNIVERSTIRY OF CONNECTICUT 2008-09-25 US claimed
US-20250032398-A1 HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2025-01-30 US disclosed
US-12096677-B2 Display device with fingerprint recognition SAMSUNG DISPLAY CO., LTD. (KR) 2024-09-17 US disclosed
CN-113036132-B Polymer composition for nonaqueous secondary battery and nonaqueous secondary battery 旭化成株式会社 2024-06-14 CN disclosed
EP-0161104-A2 Polymer emulsions and process of preparing polymer emulsions MITSUI TOATSU CHEMICALS, Inc. (JP) 1985-11-13 EP disclosed
US-4358510-A CELLULOSE ACETATE BUTYRATE GRAFTED WITH ADDITION POLYMER KANSAI PAINT CO., LTD. (JP) 1982-11-09 US disclosed
US-4324708-A CONTAINING AN ADDITION COPOLYMER MODIFIED WITH CELLULOSE ACETATE &UTYRATE KANSAI PAINT CO., LTD. (JP) 1982-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717800-B2 Controlled crosslinking of latex polymers with polyfunctional amines ALG1, LTA, LTN1 ALDH1A1 1969/4885
US-20170081451-A1 Controlled Crosslinking of Latex Polymers With Polyfunctional Amines ALG1, LTA, LTN1 ALDH1A1 1969/4885
US-20250032398-A1 HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF PCNA, ADSL, APH1B ALDH1A1 2371/4885
US-20170088694-A1 Controlled Crosslinking of Latex Polymers With Polyfunctional Amines ALG1, LTA, LTN1 ALDH1A1 1969/4885
US-20150259562-A1 Controlled Crosslinking of Latex Polymers With Polyfunctional Amines ALG1, LTA, LTN1 ALDH1A1 1969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.